Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Invested Capital (2016 - 2025)

Editas Medicine (EDIT) has disclosed Invested Capital for 11 consecutive years, with $72.5 million as the latest value for Q3 2025.

  • Quarterly Invested Capital fell 58.71% to $72.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $72.5 million through Sep 2025, down 58.71% year-over-year, with the annual reading at $191.7 million for FY2024, 45.08% down from the prior year.
  • Invested Capital for Q3 2025 was $72.5 million at Editas Medicine, down from $75.9 million in the prior quarter.
  • The five-year high for Invested Capital was $638.0 million in Q1 2021, with the low at $72.5 million in Q3 2025.
  • Average Invested Capital over 5 years is $354.3 million, with a median of $360.5 million recorded in 2023.
  • The sharpest move saw Invested Capital surged 171.99% in 2021, then plummeted 67.3% in 2025.
  • Over 5 years, Invested Capital stood at $553.6 million in 2021, then plummeted by 34.85% to $360.7 million in 2022, then dropped by 3.21% to $349.1 million in 2023, then crashed by 45.08% to $191.7 million in 2024, then plummeted by 62.17% to $72.5 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $72.5 million, $75.9 million, and $117.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.